124 related articles for article (PubMed ID: 37328356)
1. Neurodegeneration, oxidative stress and lipid metabolism plasma biomarkers to differentiate Parkinson's disease from atypical parkinsonian syndromes.
Schneider V; Vejux A; Nury T; Dupont G; Pais de Barros JP; Lakomy D; Lizard G; Moreau T
Rev Neurol (Paris); 2023 Nov; 179(9):961-966. PubMed ID: 37328356
[TBL] [Abstract][Full Text] [Related]
2. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
[TBL] [Abstract][Full Text] [Related]
3. A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes.
Li Q; Li Z; Han X; Shen X; Wang F; Bai L; Li Z; Zhang R; Wang Y; Zhu X
Front Neurosci; 2022; 16():805953. PubMed ID: 35250451
[TBL] [Abstract][Full Text] [Related]
4. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
[TBL] [Abstract][Full Text] [Related]
5. Blood neurofilament light chain in Parkinson's disease.
Buhmann C; Magnus T; Choe CU
J Neural Transm (Vienna); 2023 Jun; 130(6):755-762. PubMed ID: 37067597
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
[TBL] [Abstract][Full Text] [Related]
7. CSF and Circulating NfL as Biomarkers for the Discrimination of Parkinson Disease From Atypical Parkinsonian Syndromes: Meta-analysis.
Angelopoulou E; Bougea A; Papadopoulos A; Papagiannakis N; Simitsi AM; Koros C; Georgakis MK; Stefanis L
Neurol Clin Pract; 2021 Dec; 11(6):e867-e875. PubMed ID: 34992970
[TBL] [Abstract][Full Text] [Related]
8. Association of Neurofilament Light With the Development and Severity of Parkinson Disease.
Halloway S; Desai P; Beck T; Aggarwal N; Agarwal P; Evans D; Rajan KB;
Neurology; 2022 May; 98(22):e2185-e2193. PubMed ID: 35418452
[TBL] [Abstract][Full Text] [Related]
9. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
[TBL] [Abstract][Full Text] [Related]
10. Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease.
Sampedro F; Pérez-González R; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
Parkinsonism Relat Disord; 2020 May; 74():43-49. PubMed ID: 32334380
[TBL] [Abstract][Full Text] [Related]
11. Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis.
Haji S; Sako W; Murakami N; Osaki Y; Izumi Y
J Neural Transm (Vienna); 2022 Mar; 129(3):301-309. PubMed ID: 35178615
[TBL] [Abstract][Full Text] [Related]
12. Combined CSF α-SYN RT-QuIC, CSF NFL and midbrain-pons planimetry in degenerative parkinsonisms: From bedside to bench, and back again.
Compta Y; Painous C; Soto M; Pulido-Salgado M; Fernández M; Camara A; Sánchez V; Bargalló N; Caballol N; Pont-Sunyer C; Buongiorno M; Martin N; Basora M; Tio M; Giraldo DM; Pérez-Soriano A; Zaro I; Muñoz E; Martí MJ; Valldeoriola F
Parkinsonism Relat Disord; 2022 Jun; 99():33-41. PubMed ID: 35594661
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis.
Sako W; Murakami N; Izumi Y; Kaji R
J Neurol Sci; 2015 May; 352(1-2):84-7. PubMed ID: 25868897
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
Ge F; Ding J; Liu Y; Lin H; Chang T
Neurosci Lett; 2018 Oct; 685():35-41. PubMed ID: 30036569
[TBL] [Abstract][Full Text] [Related]
15. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
Jabbari E; Woodside J; Guo T; Magdalinou NK; Chelban V; Athauda D; Lees AJ; Foltynie T; Houlden H; Church A; Hu MT; Rowe JB; Zetterberg H; Morris HR
J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):768-773. PubMed ID: 30867224
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma NFL and disease progression in Parkinson's disease: a prospective cohort study.
Ou R; Liu K; Lin J; Yang T; Xiao Y; Wei Q; Hou Y; Li C; Zhang L; Jiang Z; Zhao B; Chen X; Song W; Wu Y; Shang H
J Neurol; 2024 Apr; 271(4):1837-1843. PubMed ID: 38063869
[TBL] [Abstract][Full Text] [Related]
17. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
[TBL] [Abstract][Full Text] [Related]
18. Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
Meloni M; Agliardi C; Guerini FR; Zanzottera M; Bolognesi E; Picciolini S; Marano M; Magliozzi A; Di Fonzo A; Arighi A; Fenoglio C; Franco G; Arienti F; Saibene FL; Navarro J; Clerici M
Neurobiol Dis; 2023 Jan; 176():105947. PubMed ID: 36481435
[TBL] [Abstract][Full Text] [Related]
19. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
[TBL] [Abstract][Full Text] [Related]
20. Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Hansson O; Janelidze S; Hall S; Magdalinou N; Lees AJ; Andreasson U; Norgren N; Linder J; Forsgren L; Constantinescu R; Zetterberg H; Blennow K;
Neurology; 2017 Mar; 88(10):930-937. PubMed ID: 28179466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
